Kentaro Inamura

13.1k total citations · 3 hit papers
140 papers, 7.2k citations indexed

About

Kentaro Inamura is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kentaro Inamura has authored 140 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 57 papers in Pulmonary and Respiratory Medicine and 54 papers in Molecular Biology. Recurrent topics in Kentaro Inamura's work include Lung Cancer Treatments and Mutations (31 papers), Lung Cancer Research Studies (22 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Kentaro Inamura is often cited by papers focused on Lung Cancer Treatments and Mutations (31 papers), Lung Cancer Research Studies (22 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Kentaro Inamura collaborates with scholars based in Japan, United States and India. Kentaro Inamura's co-authors include Yuichi Ishikawa, Sakae Okumura, Ken Nakagawa, Hironori Ninomiya, Kengo Takeuchi, Yuki Togashi, Yukitoshi Satoh, Manabu Soda, Young Lim Choi and Hiroyuki Mano and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Kentaro Inamura

125 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy

2013 1.1k citations Reiko Nishihara, Kana Wu et al. profile →
KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer

2009 557 citations Kengo Takeuchi, Young Lim Choi et al. Clinical Cancer Research profile →
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification

2017 349 citations Kentaro Inamura profile →

Peers

Kentaro Inamura

ONCOL

PRM

PFM

Yuankai Shi China

Yasuhide Yamada Japan

Mario Scartozzi Italy

Kun‐Huei Yeh Taiwan

Se Jin Jang South Korea

Jifeng Feng China

Masashi Bando Japan

Kenji Sugio Japan

David Khayat France

Yukihiko Sugiyama Japan

Yuankai Shi China

Kentaro Inamura

3.5k ×0.9

ONCOL

2.9k ×0.7

PRM

1.8k ×0.7

1.0k ×0.6

1.1k ×1.0

PFM

Citations per year, relative to Kentaro Inamura Kentaro Inamura (= 1×) peers Yuankai Shi

Countries citing papers authored by Kentaro Inamura

Since Specialization

Citations

This map shows the geographic impact of Kentaro Inamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Inamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Inamura more than expected).

Fields of papers citing papers by Kentaro Inamura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Inamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Inamura. The network helps show where Kentaro Inamura may publish in the future.

Co-authorship network of co-authors of Kentaro Inamura

This figure shows the co-authorship network connecting the top 25 collaborators of Kentaro Inamura. A scholar is included among the top collaborators of Kentaro Inamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kentaro Inamura. Kentaro Inamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takemura, Kosuke, et al.. (2025). Clinical outcomes of patients with metastatic fumarate hydratase‐deficient renal cell carcinoma: A single‐center case series. International Journal of Urology. 32(5). 601–603.

Komura, Daisuke, Takayuki Isagawa, Yusuke Amano, et al.. (2025). A Transcriptomic Analysis of Cancer‐Stromal Interactome in Lung Cancer Xenograft Models. Cancer Science. 117(3). 841–851.

Saito, Rumiko, Yasuyuki Shigematsu, Manabu Takamatsu, et al.. (2025). Association of Enterotoxigenic Bacteroides fragilis with Immune Modulation in Colorectal Cancer Liver Metastasis. Cancers. 17(17). 2733–2733.

Shigematsu, Yasuyuki, Rumiko Saito, Hiroaki Kanda, et al.. (2024). Inverse Correlation between pks-Carrying Escherichia coli Abundance in Colorectal Cancer Liver Metastases and the Number of Organs Involved in Recurrence. Cancers. 16(17). 3003–3003. 2 indexed citations

Shigematsu, Yasuyuki, Hiroaki Kanda, Yu Takahashi, et al.. (2023). MHC class I loss is associated with biliary/progenitor cell features and “cold” tumor-immune microenvironment in hepatocellular carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(2). 177–186. 5 indexed citations

Sugawara, Emiko, et al.. (2023). CDX2- and PAX8-Expressing Subtypes in Female Urethral Adenocarcinoma: Pathogenesis Insights through Immunohistochemical and Morphological Analyses. Diagnostics. 13(14). 2408–2408.

Shigematsu, Yasuyuki, Hiroaki Kanda, Yu Takahashi, et al.. (2022). Decreased ARG1 expression as an adverse prognostic phenotype in non-alcoholic non-virus-related hepatocellular carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(2). 253–263. 6 indexed citations

Inamura, Kentaro. (2020). Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics. Seminars in Cancer Biology. 70. 11–23. 37 indexed citations

Haga, Yoshimi, Motohide Uemura, Satoko Baba, et al.. (2019). Identification of Multisialylated LacdiNAc Structures as Highly Prostate Cancer Specific Glycan Signatures on PSA. Analytical Chemistry. 91(3). 2247–2254. 48 indexed citations

10.

Hashimoto, Hirotsugu, et al.. (2019). Cerebral Thromboembolism after Lobectomy for Lung Cancer: Pathological Diagnosis and Mechanism of Thrombus Formation. Cancers. 11(4). 488–488. 15 indexed citations

11.

Inamura, Kentaro, et al.. (2019). Pulmonary adenocarcinoma with mucin production and possible subtyping based on driver mutations and transcription factors. 66(1). 1–12. 1 indexed citations

12.

Inamura, Kentaro, et al.. (2019). Preparation of metal phthalocyanine (MPc)–polymer complexes: the possible anti-cancer properties of FePc–polymer complexes. Heliyon. 5(3). e01383–e01383. 3 indexed citations

13.

Inamura, Kentaro, Naoko Ozawa, Takashi Endo, et al.. (2017). Skene's gland adenocarcinoma with intestinal differentiation: A case report and literature review. Pathology International. 67(11). 575–579. 15 indexed citations

14.

McCleary, Nadine J., Kaori Sato, Reiko Nishihara, et al.. (2015). Prognostic Utility of Molecular Factors by Age at Diagnosis of Colorectal Cancer. Clinical Cancer Research. 22(6). 1489–1498. 11 indexed citations

15.

Fujiwara, Takeshi, Miyako Hiramatsu, Takayuki Isagawa, et al.. (2011). ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis. Lung Cancer. 75(1). 119–125. 40 indexed citations

16.

Takeuchi, Kengo, Young Lim Choi, Yuki Togashi, et al.. (2009). KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer. Clinical Cancer Research. 15(9). 3143–3149. 557 indexed citations breakdown →

17.

Choi, Young Lim, Kengo Takeuchi, Manabu Soda, et al.. (2008). Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non–Small Cell Lung Cancer. Cancer Research. 68(13). 4971–4976. 346 indexed citations

18.

Takeuchi, Kengo, Young Lim Choi, Manabu Soda, et al.. (2008). Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts. Clinical Cancer Research. 14(20). 6618–6624. 397 indexed citations

19.

Hiramatsu, Miyako, Hironori Ninomiya, Kentaro Inamura, et al.. (2007). EGFR signal pathways selectively activated in lung adenocarcinoma.. Cancer Research. 67. 5038–5038. 1 indexed citations

20.

Ueda, Takanori, Masahiro Okamoto, Naoya Uematsu, et al.. (2002). Inference of Genetic Network Using the Expression Profile Time Course Data of Mouse P19 Cells. Proceedings Genome Informatics Workshop/Genome informatics. 13. 382–383. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact